February 3, 2026 · Form 4 insider transaction
Guyer William sold 20,000 shares of Corcept Therapeutics Incorporated at $40.87 per share, a transaction worth $817.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.; Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $40.71 to $41.2804 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.